Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic Inflammation
Signal transducer and activator of transcription 3 (STAT3) is implicated in inflammation processing, but the mechanism of its regulation mostly remains limited to Janus kinase (JAK)-mediated phosphorylation. Although AMP-activated protein kinase (AMPK)-mediated STAT3 inactivation has got documented,...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00414/full |
id |
doaj-0bd54e107b9c4fe585dd02cb5db38094 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hui Gong Haoran Tai Haoran Tai Ning Huang Peng Xiao Chunfen Mo Chunfen Mo Xiaobo Wang Xiaojuan Han Jiao Zhou Honghan Chen Xiaoqiang Tang Tingting Zhao Weitong Xu Chuhui Gong Gongchang Zhang Yu Yang Shuang Wang Hengyi Xiao |
spellingShingle |
Hui Gong Haoran Tai Haoran Tai Ning Huang Peng Xiao Chunfen Mo Chunfen Mo Xiaobo Wang Xiaojuan Han Jiao Zhou Honghan Chen Xiaoqiang Tang Tingting Zhao Weitong Xu Chuhui Gong Gongchang Zhang Yu Yang Shuang Wang Hengyi Xiao Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic Inflammation Frontiers in Immunology AMPK STAT3 Nrf2 SHP LPS inflammation |
author_facet |
Hui Gong Haoran Tai Haoran Tai Ning Huang Peng Xiao Chunfen Mo Chunfen Mo Xiaobo Wang Xiaojuan Han Jiao Zhou Honghan Chen Xiaoqiang Tang Tingting Zhao Weitong Xu Chuhui Gong Gongchang Zhang Yu Yang Shuang Wang Hengyi Xiao |
author_sort |
Hui Gong |
title |
Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic Inflammation |
title_short |
Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic Inflammation |
title_full |
Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic Inflammation |
title_fullStr |
Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic Inflammation |
title_full_unstemmed |
Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic Inflammation |
title_sort |
nrf2-shp cascade-mediated stat3 inactivation contributes to ampk-driven protection against endotoxic inflammation |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2020-03-01 |
description |
Signal transducer and activator of transcription 3 (STAT3) is implicated in inflammation processing, but the mechanism of its regulation mostly remains limited to Janus kinase (JAK)-mediated phosphorylation. Although AMP-activated protein kinase (AMPK)-mediated STAT3 inactivation has got documented, the molecular signaling cascade connecting STAT3 inactivation and the anti-inflammatory role of AMPK is far from established. In the present study, we addressed the interplay between AMPK and STAT3, and revealed the important role of STAT3 inactivation in the anti-inflammatory function of AMPK in lipopolysaccharide-stressed macrophages and mice. Firstly, we found that pharmacological inhibition of STAT3 can improve the anti-inflammatory effect of AMPK in wild-type mice, and the expression of STAT3 in macrophage of mice is a prerequisite for the anti-inflammatory effect of AMPK. As to the molecular signaling cascade linking AMPK to STAT3, we disclosed that AMPK suppressed STAT3 not only by attenuating JAK signaling but also by activating nuclear factor erythroid-2-related factor-2 (Nrf2), a redox-regulating transcription factor, which consequently increased the expression of small heterodimer protein (SHP), thus repressing the transcriptional activity of STAT3. In summary, this study provided a unique set of evidence showing the relationship between AMPK and STAT3 signaling and explored a new mechanism of AMPK-driven STAT3 inactivation that involves Nrf2-SHP signaling cascade. These findings expand our understanding of the interplay between pro- and anti-inflammatory signaling pathways and are beneficial for the therapeutic development of sepsis treatments. |
topic |
AMPK STAT3 Nrf2 SHP LPS inflammation |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2020.00414/full |
work_keys_str_mv |
AT huigong nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT haorantai nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT haorantai nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT ninghuang nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT pengxiao nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT chunfenmo nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT chunfenmo nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT xiaobowang nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT xiaojuanhan nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT jiaozhou nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT honghanchen nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT xiaoqiangtang nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT tingtingzhao nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT weitongxu nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT chuhuigong nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT gongchangzhang nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT yuyang nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT shuangwang nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation AT hengyixiao nrf2shpcascademediatedstat3inactivationcontributestoampkdrivenprotectionagainstendotoxicinflammation |
_version_ |
1724890990235353088 |
spelling |
doaj-0bd54e107b9c4fe585dd02cb5db380942020-11-25T02:16:30ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-03-011110.3389/fimmu.2020.00414515660Nrf2-SHP Cascade-Mediated STAT3 Inactivation Contributes to AMPK-Driven Protection Against Endotoxic InflammationHui Gong0Haoran Tai1Haoran Tai2Ning Huang3Peng Xiao4Chunfen Mo5Chunfen Mo6Xiaobo Wang7Xiaojuan Han8Jiao Zhou9Honghan Chen10Xiaoqiang Tang11Tingting Zhao12Weitong Xu13Chuhui Gong14Gongchang Zhang15Yu Yang16Shuang Wang17Hengyi Xiao18From the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaDevelopment and Regeneration Key Lab of Sichuan Province, Department of Anatomy and Histology and Embryology, Chengdu Medical College, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaKey Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaFrom the Lab for Aging Research, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, ChinaSignal transducer and activator of transcription 3 (STAT3) is implicated in inflammation processing, but the mechanism of its regulation mostly remains limited to Janus kinase (JAK)-mediated phosphorylation. Although AMP-activated protein kinase (AMPK)-mediated STAT3 inactivation has got documented, the molecular signaling cascade connecting STAT3 inactivation and the anti-inflammatory role of AMPK is far from established. In the present study, we addressed the interplay between AMPK and STAT3, and revealed the important role of STAT3 inactivation in the anti-inflammatory function of AMPK in lipopolysaccharide-stressed macrophages and mice. Firstly, we found that pharmacological inhibition of STAT3 can improve the anti-inflammatory effect of AMPK in wild-type mice, and the expression of STAT3 in macrophage of mice is a prerequisite for the anti-inflammatory effect of AMPK. As to the molecular signaling cascade linking AMPK to STAT3, we disclosed that AMPK suppressed STAT3 not only by attenuating JAK signaling but also by activating nuclear factor erythroid-2-related factor-2 (Nrf2), a redox-regulating transcription factor, which consequently increased the expression of small heterodimer protein (SHP), thus repressing the transcriptional activity of STAT3. In summary, this study provided a unique set of evidence showing the relationship between AMPK and STAT3 signaling and explored a new mechanism of AMPK-driven STAT3 inactivation that involves Nrf2-SHP signaling cascade. These findings expand our understanding of the interplay between pro- and anti-inflammatory signaling pathways and are beneficial for the therapeutic development of sepsis treatments.https://www.frontiersin.org/article/10.3389/fimmu.2020.00414/fullAMPKSTAT3Nrf2SHPLPSinflammation |